Aditxt, Inc.
Aditxt, Inc. (ADTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ADTX · as of Jun 9, 2026
Key Statistics
Explore Aditxt, Inc. Data
adtx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
The ADTX analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $1280.00, representing +2565030.26% upside from the current price of $0.05.
Competitors & Peers
adtx competitorsADTX
AIMD
ANL
APLM
ATHA
BLRXStock Performance
Full HistoryAbout Aditxt, Inc.
Aditxt, Inc. is a biotechnology firm dedicated to advancing immune system health through innovative mapping and reprogramming techniques. The company's developments include AditxtScore, a platform des…
what is aditxt, inc. · adtx stock overview · aditxt, inc. company profile · who is aditxt, inc. ceo · adtx NASDAQ · aditxt, inc. headquarters · aditxt, inc. business segments
About Stock Overview & Key Data
Aditxt, Inc. (ADTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 30, 2020. As of the latest trading session, ADTX stock price is $0.05, with a market capitalization of $1,672. The stock has returned -100.00% over the past 12 months and -99.97% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Aditxt, Inc. stock is Buy, with an average 12-month price target of $1280.00. In fiscal year 2025, Aditxt, Inc. reported revenue of $3195.00 and net income of -$41.7M. For detailed data — including Aditxt, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aditxt, Inc. (ADTX) stock price is $0.05. The stock is traded on NASDAQ under the ticker symbol ADTX. The 52-week range is $0.05 – $53453.52.